Yıl: 2013 Cilt: 28 Sayı: 2 Sayfa Aralığı: 136 - 140 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack

Öz:
Tipik olarak tekrarlayan akut ataklardan sonra gelişen gut tofüsü, tüm gut olgularının %10'unda görülür. Gut öncelikle erkek hastalığı olarak bilinmesine rağmen, hastaların %5'inde kadınları etkiler ve bunların büyük çoğunluğu ilk atak sırasında postmenopozal dönemdedir. Gut tofüsü, kadınlarda sıklıkla poliartikülerdir. İnflamatuar eklem hastalığı olmaksızın yumuşak doku kitlesi olarak görülen soliter tofüs, neoplastik durumlarla karıştırılabilir. Bu yazıda, hiperürisemi veya akut enflamatuvar gut atağı olmaksızın atipik yerleşimli gut tofüsü olan 30 yaşında bir kadın olgu sunuldu.
Anahtar Kelime:

Konular: Romatoloji

Hiperürisemi veya İnflamatuar Gut Atağı Olmaksızın Atipik Yerleşimli Gut Tofüsü

Öz:
Tophaceous gout which typically develops following recurrent acute attacks, accounts for 10% of all gout cases. Although gout is known as a condition which primarily affects male gender, 5% of the patients are women with the majority being postmenopausal during the first attack. Tophaceous gout is frequently polyarticular in women. A solitary tophus which is seen as a soft tissue mass without inflammatory joint disease can be confused with neoplastic conditions. In this article, we report a 30-year-old female case of tophaceous gout with atypical localization presenting without hyperuricemia or an acute inflammatory gout attack.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • Rodnan GP, Schumacher HR, editors. Primer on the rheumatic diseases. 8th ed. Atlanta, GA: Arhtritis Foundation; 1983. p.120-7.
  • Falidas E, Rallis E, Bournia VK, Mathioulakis S, Pavlakis E, Villias C. Multiarticular chronic tophaceous gout with severe and multiple ulcerations: a case report. J Med Case Rep 2011;5:397. doi: 10.1186/1752-1947-5-397.
  • Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007;46:1804-7.
  • Dhoble A, Balakrishnan V, Smith R. Chronic tophaceous gout presenting as acute arthritis during an acute illness: a case report. Cases J 2008;1:238. doi: 10.1186/1757-1626- 1-238.
  • Davis JC Jr. A practical approach to gout. Current management of an 'old' disease. Postgrad Med 1999;106:115-6, 119-23.
  • Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA 1991;266:3004-7.
  • Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7.
  • Underwood M. Diagnosis and management of gout. BMJ 2006;332:1315-9.
  • Guzel R, Sarpel T, Kozanoglu E, Paydas S. Chronic tophaceous gout in a premenapousal patient with familial nephropathy. Ege Fiz Tıp Reh Der 2001;7:141-5.
  • Dorsey ML, Roberts CC. Tophaceous gout mimicking an edematous Anconeus epitrochlearis. RCR 2006;1:140-4.
  • Li EK. Gout: a review of its aetiology and treatment. Hong Kong Med J 2004;10:261-70.
  • Logan JA, Morrison E, McGill PE. Serum uric acid in acute gout. Ann Rheum Dis 1997;56:696-7.
  • Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005;11:S443-50.
  • Wernick R, Winkler C, Campbell S. Tophi as the initial manifestation of gout. Report of six cases and review of the literature. Arch Intern Med 1992;152:873-6.
  • Neogi T. Clinical practice. Gout. N Engl J Med 2011;364:443-52. doi: 10.1056/NEJMcp1001124.
  • Hoskison TK, Wortmann RL. Advances in the management of gout and hyperuricaemia. Scand J Rheumatol 2006;35:251-60.
  • Sunkureddi P, Nguyen-Oghalai TU, Karnath BM. Clinical signs of gout. Hospital Physician 2006;42:39-42, 47.
  • Champion D. Gouty tenosynovitis and the carpal tunnel syndrome. Med J Aust 1969;1:1030-2.
  • Martínez-Cordero E, Barreira-Mercado E, Katona G. Eye tophi deposition in gout. J Rheumatol 1986;13:471-3.
  • Iacobellis G, Iacobellis G. A rare and asymptomatic case of mitral valve tophus associated with severe gouty tophaceous arthritis. J Endocrinol Invest 2004;27:965-6.
  • Meyers OL, Monteagudo FS. A comparison of gout in men and women. A 10-year experience. S Afr Med J 1986;70:721-3.
  • Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
  • Khandpur S, Minz AK, Sharma VK. Chronic tophaceous gout with severe deforming arthritis. Indian J Dermatol Venereol Leprol 2010;76:69-71. doi: 10.4103/0378-6323.58689.
  • Brower AC, Flemming DJ. Gout. In: Brower AC, Flemming DJ, editors. Arthritis: in black and white. 2nd ed. Philadelphia: W.B. Saunders; 1997. p. 325-41.
  • Yu JS, Chung C, Recht M, Dailiana T, Jurdi R. MR imaging of tophaceous gout. AJR Am J Roentgenol 1997;168:523-7.
  • Chen CK, Chung CB, Yeh L, Pan HB, Yang CF, Lai PH, et al. Carpal tunnel syndrome caused by tophaceous gout: CT and MR imaging features in 20 patients. AJR Am J Roentgenol 2000;175:655-9.
  • Ruiz ME, Erickson SJ, Carrera GF, Hanel DP, Smith MD. Monoarticular gout following trauma: MR appearance. J Comput Assist Tomogr 1993;17:151-3.
  • Rubenstein J, Pritzker KP. Crystal-associated arthropathies. AJR Am J Roentgenol 1989;152:685-95.
  • Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology (Oxford) 2009;48 Suppl 2:ii9-ii14. doi: 10.1093/rheumatology/kep087.
  • Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Palo WA, Eustace D, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 2005;52:916-23.
  • Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, et al. Quality of care indicators for gout management. Arthritis Rheum 2004;50:937-43.
  • Wortmann RL, Kelley WN. Gout and hyperuricemia. In: Harris ED Jr, Budd RC, Firestein GS, Enovese MC, Sergent JS, Ruddy S, et al, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Saunders/Elsevier; 2004. p.1402-29.
  • Terkeltaub RA. Gout. Epidemiology, pathology and pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, White PN, editors. Primer on the rheumatic diseases. 12th ed. Atlanta: Arthritis Foundation; 2001. p. 307-12.
APA TOSUN H, SERBEST S, BALOĞLU M, İNANMAZ M, KÖSE K (2013). Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. , 136 - 140.
Chicago TOSUN Hacı Bayram,SERBEST Sancar,BALOĞLU MURAT,İNANMAZ Mustafa Erkan,KÖSE Kamil Çağrı Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. (2013): 136 - 140.
MLA TOSUN Hacı Bayram,SERBEST Sancar,BALOĞLU MURAT,İNANMAZ Mustafa Erkan,KÖSE Kamil Çağrı Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. , 2013, ss.136 - 140.
AMA TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. . 2013; 136 - 140.
Vancouver TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. . 2013; 136 - 140.
IEEE TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K "Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack." , ss.136 - 140, 2013.
ISNAD TOSUN, Hacı Bayram vd. "Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack". (2013), 136-140.
APA TOSUN H, SERBEST S, BALOĞLU M, İNANMAZ M, KÖSE K (2013). Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. Turkish Journal of Rheumatology(.)Archives of Rheumatology, 28(2), 136 - 140.
Chicago TOSUN Hacı Bayram,SERBEST Sancar,BALOĞLU MURAT,İNANMAZ Mustafa Erkan,KÖSE Kamil Çağrı Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. Turkish Journal of Rheumatology(.)Archives of Rheumatology 28, no.2 (2013): 136 - 140.
MLA TOSUN Hacı Bayram,SERBEST Sancar,BALOĞLU MURAT,İNANMAZ Mustafa Erkan,KÖSE Kamil Çağrı Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. Turkish Journal of Rheumatology(.)Archives of Rheumatology, vol.28, no.2, 2013, ss.136 - 140.
AMA TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2013; 28(2): 136 - 140.
Vancouver TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2013; 28(2): 136 - 140.
IEEE TOSUN H,SERBEST S,BALOĞLU M,İNANMAZ M,KÖSE K "Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack." Turkish Journal of Rheumatology(.)Archives of Rheumatology, 28, ss.136 - 140, 2013.
ISNAD TOSUN, Hacı Bayram vd. "Tophaceous Gout with Atypical Localization without Hyperuricemia or an Inflammatory Gout Attack". Turkish Journal of Rheumatology(.)Archives of Rheumatology 28/2 (2013), 136-140.